Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients. Effetti Del Temperamento, Dell'Ansia e Della Depressione Sulla Sopravvivenza Globale e Sulla Risposta Immunitaria Del Paziente Affetto da Adenocarcinoma Colo-Rettale.
|ClinicalTrials.gov Identifier: NCT01433146|
Recruitment Status : Completed
First Posted : September 13, 2011
Last Update Posted : June 6, 2012
|Condition or disease|
|Temperament Anxiety Depression Colorectal Cancer|
120 prospective patients, with non-metastatic colorectal cancer, will be evaluated with questionnaires and auto-questionnaires in order to assess temperament, anxiety and depression. The immunity status will be assessed by a blood sample with the aim to evaluate cell-mediated immunity.
Survivall will be related to level of anxiety/temperament/depression and cell-mediated immunity.
Univariate and multivariate model analisys will be performed in order to evaluate if anxiety/temperament/depression and cell-mediated immunity can be considered as prognostic factors.
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients.|
|Study Start Date :||September 2011|
|Primary Completion Date :||January 2012|
|Study Completion Date :||June 2012|
- Temperament in non-metastatic colorectal cancer patients [ Time Frame: 24 months ]Evaluation if Temperament can be considered as dependent or indipendent prognostic factor for survival in non-metastatic colorectal cancer patients
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01433146
|"Sapienza" University of Rome|
|Rome, Italy, 00100|
|Principal Investigator:||Marco La Torre, MD||"Sapienza" University of Rome|